Examines prescribing patterns of GLP-1 receptor agonists in adolescents with obesity, suggesting disparities exist.
This study examines the prescribing of glucagon-like peptide-1 receptor agonists for adolescents with obesity and associated disparities.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: